| Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy F Pastorino, C Brignole, D Marimpietri, M Cilli, C Gambini, D Ribatti, ... Cancer research 63 (21), 7400-7409, 2003 | 401 | 2003 |
| TIMP‐2 over‐expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis P Valente, G Fassina, A Melchiori, L Masiello, M Cilli, A Vacca, M Onisto, ... International journal of cancer 75 (2), 246-253, 1998 | 380 | 1998 |
| Targeting liposomal chemotherapy via both tumor cell–specific and tumor vasculature–specific ligands potentiates therapeutic efficacy F Pastorino, C Brignole, D Di Paolo, B Nico, A Pezzolo, D Marimpietri, ... Cancer research 66 (20), 10073-10082, 2006 | 292 | 2006 |
| Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome C Lunardi, C Bason, M Leandri, R Navone, M Lestani, E Millo, U Benatti, ... The Lancet 360 (9337), 915-921, 2002 | 280 | 2002 |
| The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice B Bachmeier, A Nerlich, C Iancu, M Cilli, E Schleicher, R Vené, R Dell'Eva, ... Cellular physiology and biochemistry 19 (1-4), 137-152, 2007 | 279 | 2007 |
| Fasting-mimicking diet and hormone therapy induce breast cancer regression I Caffa, V Spagnolo, C Vernieri, F Valdemarin, P Becherini, M Wei, ... Nature 583 (7817), 620-624, 2020 | 262 | 2020 |
| Clonal analysis of stably transduced human epidermal stem cells in culture. MB Mathor, G Ferrari, E Dellambra, M Cilli, F Mavilio, R Cancedda, ... Proceedings of the National Academy of Sciences 93 (19), 10371-10376, 1996 | 206 | 1996 |
| p49, a putative HLA class I‐specific inhibitory NK receptor belonging to the immunoglobulin superfamily C Cantoni, S Verdiani, M Falco, A Pessino, M Cilli, R Conte, D Pende, ... European journal of immunology 28 (6), 1980-1990, 1998 | 192 | 1998 |
| Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis C Brignole, D Marimpietri, F Pastorino, B Nico, D Di Paolo, M Cioni, ... Journal of the National Cancer Institute 98 (16), 1142-1157, 2006 | 159 | 2006 |
| Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer C Marini, B Salani, M Massollo, A Amaro, AI Esposito, A Maria Orengo, ... Cell cycle 12 (22), 3490-3499, 2013 | 147 | 2013 |
| Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy I Airoldi, E Di Carlo, C Cocco, C Sorrentino, F Fais, M Cilli, T D'Antuono, ... Blood 106 (12), 3846-3853, 2005 | 139 | 2005 |
| Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model T Mirabella, M Cilli, S Carlone, R Cancedda, C Gentili Biomaterials 32 (15), 3689-3699, 2011 | 127 | 2011 |
| Bone turnover in wild type and pleiotrophin-transgenic mice housed for three months in the International Space Station (ISS) S Tavella, A Ruggiu, A Giuliani, F Brun, B Canciani, A Manescu, ... PloS one 7 (3), e33179, 2012 | 116 | 2012 |
| Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin F Pastorino, D Di Paolo, F Piccardi, B Nico, D Ribatti, A Daga, G Baio, ... Clinical Cancer Research 14 (22), 7320-7329, 2008 | 110 | 2008 |
| Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor MM Santoro, L Penengo, M Minetto, S Orecchia, M Cilli, G Gaudino Oncogene 17 (6), 741-749, 1998 | 104 | 1998 |
| Retracted: Role of α7‐nicotinic acetylcholine receptor in human non‐small cell lung cancer proliferation L Paleari, A Catassi, M Ciarlo, Z Cavalieri, C Bruzzo, D Servent, A Cesario, ... Cell proliferation 41 (6), 936-959, 2008 | 103 | 2008 |
| Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies E Gazzerro, S Assereto, A Bonetto, F Sotgia, S Scarfì, A Pistorio, ... The American journal of pathology 176 (4), 1863-1877, 2010 | 99 | 2010 |
| Down-regulation of lysyl oxidase-induced tumorigenic transformation in NRK-49F cells characterized by constitutive activation of ras proto-oncogene M Giampuzzi, G Botti, M Cilli, R Gusmano, A Borel, P Sommer, ... Journal of Biological Chemistry 276 (31), 29226-29232, 2001 | 98 | 2001 |
| Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model P Bocca, E Di Carlo, I Caruana, L Emionite, M Cilli, B De Angelis, ... Oncoimmunology 7 (1), e1378843, 2018 | 95 | 2018 |
| Natural agents targeting the α7‐nicotinic‐receptor in NSCLC: A promising prospective in anti‐cancer drug development A Grozio, L Paleari, A Catassi, D Servent, M Cilli, F Piccardi, M Paganuzzi, ... International journal of cancer 122 (8), 1911-1915, 2008 | 94 | 2008 |
